Feliqs Corporation

Bioscience & Disease Healthcare Systems

@FeliqsCorp Website LinkedIn Fukuoka, Japan

About Feliqs Corporation

A biotechnology company developing first-in-class small molecule therapeutics targeting oxidized lipids for rare pediatric retinal diseases.

Business Information

Target Customers

healthcare providers research institutions pharmaceutical companies

Industry Categories

Bioscience & Disease Healthcare Systems

Business Model

Revenue Model B2B

Pricing Strategy N/A

Sales Channels direct sales, partnerships with healthcare organizations

Funding Timeline

Round	Date	Amount	Investors
Series A	Jul 01, 2025	$9.0M	Unknown

Founders

No founder information available.

Investors

No investor information available.

Recent Mentions

FinSMEs @finSMEs

Jul 01, 2025

Feliqs Corporation, a Fukuoka, Japan-based biotechnology company developing first-in-class small molecule therapeutics targeting oxidized lipids for rare pediatric retinal diseases, closed a $9m Series A funding round https://t.co/GxB6FJsyxH

View on Twitter

Similar Startups

Illimis Therapeutics

86% match

Illimis Therapeutics is a biotechnology company focused on developing innovative therapies to addres...

Azafaros

85% match

Azafaros is a biotechnology company focused on developing innovative therapies for rare diseases, le...

Alpheus Medical

85% match

A private, clinical-stage oncology company focused on developing innovative therapies for cancer tre...

Longbio

84% match

Longbio Pharma is a biotech startup focused on developing innovative therapies for autoimmune and ra...